1577. Real-World, Multicenter Experience with Eravacycline for Various Infections

BACKGROUND: Eravacycline (ERV) is Food and Drug Administration approved in patients for the treatment of adults complicated intra-abdominal infections in 2018. Real-world data regarding the indications for ERV use are is limited. We evaluated the clinical/safety outcomes of patients treated with ERV...

Descripción completa

Detalles Bibliográficos
Autores principales: Alosaimy, Sara, Lagnf, Abdalhamid M, Molina, Kyle, King, Madeline, Pullinger, Benjamin, Tart, Serina, Jones, Bruce M, Claeys, Kimberly C, Truong, James, Andrade, Justin A, Biagi, Mark, Pierce, Michael, Cosimi, Reese, Hobbs, Athena L V, Perkins, Nicholson, Huang, Glen, Veve, Michael, Morrisette, Taylor, Davis, Susan L, Rybak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777677/
http://dx.doi.org/10.1093/ofid/ofaa439.1757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777677/
http://dx.doi.org/10.1093/ofid/ofaa439.1757

Ejemplares similares